Viewing Study NCT05676203


Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2025-12-25 @ 4:52 PM
Study NCT ID: NCT05676203
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-17
First Post: 2022-12-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients
Sponsor: Jena University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module